Endovascular approach as first-line therapy for congenital arteriovenous malformations – a case series
DOI:
https://doi.org/10.48750/acv.488Keywords:
Arteriovenous malformation, vascular anomalies, embolization, endovascular, Yakes ClassificationAbstract
INTRODUCTION: Congenital vascular malformations are entities with a broad spectrum of presentations and variable prognosis. They typically present at a young age and are historically associated with extensive resection surgeries and with high morbidity. This study aims to evaluate the results of arteriovenous malformations (AVMs) embolization as a first-line approach in lesions which are not suitable for surgical resection.
METHODS: A retrospective analysis of the clinical records of patients with infiltrative arteriovenous malformations who underwent embolization at our center between 2019 and 2021 was performed. The Schobinger Classification was applied to categorize the clinical stage. Angiographic findings were reported according to the Yakes classification. The decrease in the Schöbinger grade after treatment, the need for reintervention and the associated complications were the main outcomes. A descriptive statistical analysis was performed.
RESULTS: Nine patients undergoing embolization of infiltrative arteriovenous malformations were evaluated, accounting for a total of seventeen interventions. There was a preponderance of females (n=6; 66.7%) and the mean age of referral to the Vascular Surgery consultation and the first treatment was 16.8 (±12.9) and 20.9 (± 14.5) years, respectively. All patients were in stage II (n=4; 44.4%) or III (n=5; 55.6%) of Schöbinger. The angiographic pattern of the AVMs was classified according to the Yakes Classification, which guided the approach. Yakes type IIa was found most frequently (n=6; 55.6%), followed by type IV (n=2; 22.2%) and type IIb (n=1; 1.1%). Patients underwent AVM embolization via transarterial, transvenous or direct nidus puncture with sclerosing agents, liquid embolizers, microparticles and microcoils, separately or in combination. The median number of interventions per patient was 1 (1 – 5) and Yakes type IV appears to be associated with a higher rate of reintervention. Reduction of the Schöbinger stage was achieved in 7 (77.8%) patients with clinical resolution in 3 (33.3%). Tissue necrosis was the only complication reported in this series (n=2; 11,8%).
CONCLUSION: The endovascular approach of arteriovenous malformations through nidus and/or afferent/ efferent embolization requires a detailed angiographic characterization but seems to be an effective strategy with a low risk of complications. The Yakes classification, can be useful both in guiding the approach and inpredicting the need for reintervention.
Downloads
References
Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyon WS. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg. 2004;39:590-600.
Lee BB. New approaches to the treatment of congenital vascular malformations (CVMs)--a single centre experience. Eur J Vasc Endovasc Surg. 2005;30:184-97.
Zou Y, Qiao C, Lin X, Jin Y, Hua C, Yang X, et al. Clinical Course of Extracranial Arteriovenous Malformations. J Craniofac Surg. 2020;31:372-6.
Chastanet S, Maruani A, Laure B, Herbreteau D, Joly A. Effect of Beta- blockers on Extracranial Arteriovenous Malformations. Acta Derm Venereol. 2022;102:adv00680.
Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg. 1998;102:643-54.
Schmidt VF, Masthoff M, Czihal M, Cucuruz B, Häberle B, Brill R, et al. Imaging of peripheral vascular malformations - current concepts and future perspectives. Mol Cell Pediatr. 2021;8:19.
Liu AS, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg. 2010;125:1185-94.
Frey S, Haine A, Kammer R, von Tengg-Kobligk H, Obrist D, Baumgartner I. Hemodynamic Characterization of Peripheral Arterio-venous Malformations. Ann Biomed Eng. 2017;45:1449-61.
Richter GT, Suen JY. Clinical course of arteriovenous malformations of the head and neck: a case series. Otolaryngology--head and neck surgery: Otolaryngol Head Neck Surg. 2010;142:184-90.
Hawkins CM, Chewning RH. Diagnosis and Management of Extracranial Vascular Malformations in Children: Arteriovenous Malformations, Venous Malformations, and Lymphatic Malformations. Semin Roentgenol. 2019;54:337-48.
Villavicencio B-BLeJL. Congenital Vascular Malformations : General Considerations. Rutherford's Vascular Surgery and Endovascular Therapy, . Chapter 171. p. 2236-50.e4.
Daniel M. O'Mara CRW. Congenital Vascular Malformations: Endovascular Management. Rutherford's Vascular Surgery and Endovascular Therapy. p. 2259-72.e2.
Soulez G, Gilbert Md Frcpc P, Giroux Md Frcpc MF, Racicot Md Frcpc JN, Dubois J. Interventional Management of Arteriovenous Malformations. Tech Vasc Interv Radiol. 2019;22:100633.
Dmytriw AA, Ter Brugge KG, Krings T, Agid R. Endovascular treatment of head and neck arteriovenous malformations. Neuroradiology. 2014;56(3):227- 36.
Kim B, Kim K, Jeon P, Kim S, Kim H, Byun H, et al. Long-term results of ethanol sclerotherapy with or without adjunctive surgery for head and neck arteriovenous malformations. Neuroradiology. 2015;57:377-86
Pekkola J, Lappalainen K, Vuola P, Klockars T, Salminen P, Pitkäranta A. Head and neck arteriovenous malformations: results of ethanol sclerotherapy. Am J Neuroradiol. 2013;34:198-204.
Vogelzang RL, Atassi R, Vouche M, Resnick S, Salem R. Ethanol embolotherapy of vascular malformations: clinical outcomes at a single center. J Vasc Interv Radiol. 2014;25:206-13; quiz 14.
Zheng LZ, Fan XD, Zheng JW, Su LX. Ethanol embolization of auricular arteriovenous malformations: preliminary results of 17 cases. Am J Neuroradiol. 2009;30:1679-84.
Jin Y, Lin X, Chen H, Hu X, Fan X, Li W, et al. Auricular arteriovenous malformations: potential success of superselective ethanol embolotherapy. J Vasc Interv Radiol. 2009;20:736-43.
Qu ZY, Yang B, Yang FY, Liao ZY. Efficiency and safety of ethanol sclerotherapy for labial arteriovenous malformations. J Vasc Surg Venous Lymphat Disord. 2022;10:713-20.e1.
Bouwman FCM, Botden S, Verhoeven BH, Schultze Kool LJ, van der Vleuten CJM, de Blaauw I, et al. Treatment Outcomes of Embolization for Peripheral Arteriovenous Malformations. J Vasc Interv Radiol. 2020;31:1801-9.
Griauzde J, Wilseck ZM, Chaudhary N, Pandey AS, Vercler CJ, Kasten SJ, et al. Endovascular Treatment of Arteriovenous Malformations of the Head and Neck: Focus on the Yakes Classification and Outcomes. J Vasc Interv Radiol. 2020;31:1810-6.
Rosenberg TL, Suen JY, Richter GT. Arteriovenous Malformations of the Head and Neck. Otolaryngol Clin of North Am. 2018;51:185-95.
Colletti G, Dalmonte P, Moneghini L, Ferrari D, Allevi F. Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations. Med Hypotheses. 2015;85:298-302.
Blatt J, McLean TW, Castellino SM, Burkhart CN. A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations. Pharmacol Ther. 2013;139:327-33.
Lekwuttikarn R, Lim YH, Admani S, Choate KA, Teng JMC. Genotype- Guided Medical Treatment of an Arteriovenous Malformation in a Child. JAMA Dermatol. 2019;155:256-7.
